Generative AI drug and target discovery company using deep learning to design next-generation antibody therapeutics.
Pricing
Custom pricing
Founded
2011
Team size
201-500 employees
About AbSci
Generative AI drug and target discovery company using deep learning to design next-generation antibody therapeutics.